Zinc in PDB 4zg9: Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds
Enzymatic activity of Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds
All present enzymatic activity of Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds:
3.1.4.39;
Protein crystallography data
The structure of Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds, PDB code: 4zg9
was solved by
A.J.Stein,
G.Bain,
J.H.Hutchinson,
J.F.Evans,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.86 /
2.95
|
Space group
|
C 2 2 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
127.460,
209.991,
188.193,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
17.9 /
24.4
|
Other elements in 4zg9:
The structure of Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds
(pdb code 4zg9). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds, PDB code: 4zg9:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 4zg9
Go back to
Zinc Binding Sites List in 4zg9
Zinc binding site 1 out
of 4 in the Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn903
b:46.1
occ:1.00
|
OD1
|
A:ASP312
|
2.1
|
46.9
|
1.0
|
NE2
|
A:HIS316
|
2.1
|
46.5
|
1.0
|
NE2
|
A:HIS475
|
2.2
|
35.9
|
1.0
|
O2
|
A:EDO910
|
2.4
|
48.4
|
1.0
|
OD2
|
A:ASP312
|
2.7
|
52.9
|
1.0
|
CG
|
A:ASP312
|
2.7
|
48.3
|
1.0
|
CE1
|
A:HIS316
|
2.8
|
48.1
|
1.0
|
CE1
|
A:HIS475
|
3.1
|
37.5
|
1.0
|
CD2
|
A:HIS316
|
3.2
|
48.2
|
1.0
|
CD2
|
A:HIS475
|
3.2
|
38.2
|
1.0
|
C2
|
A:EDO910
|
3.3
|
53.6
|
1.0
|
O
|
A:HOH1003
|
3.5
|
31.5
|
1.0
|
ND1
|
A:HIS316
|
4.0
|
46.7
|
1.0
|
CB
|
A:ASP312
|
4.2
|
47.6
|
1.0
|
CG
|
A:HIS316
|
4.2
|
48.0
|
1.0
|
ND1
|
A:HIS475
|
4.3
|
37.7
|
1.0
|
CE1
|
A:HIS360
|
4.3
|
36.2
|
1.0
|
CG
|
A:HIS475
|
4.4
|
38.0
|
1.0
|
OG1
|
A:THR210
|
4.4
|
50.9
|
1.0
|
NE2
|
A:HIS360
|
4.6
|
37.9
|
1.0
|
OD1
|
A:ASP172
|
4.7
|
62.8
|
1.0
|
CE
|
A:MET362
|
4.7
|
46.8
|
1.0
|
C1
|
A:EDO910
|
4.7
|
55.1
|
1.0
|
ZN
|
A:ZN904
|
5.0
|
99.0
|
1.0
|
|
Zinc binding site 2 out
of 4 in 4zg9
Go back to
Zinc Binding Sites List in 4zg9
Zinc binding site 2 out
of 4 in the Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn904
b:99.0
occ:1.00
|
OD1
|
A:ASP172
|
1.8
|
62.8
|
1.0
|
OD2
|
A:ASP359
|
2.0
|
61.7
|
1.0
|
OG1
|
A:THR210
|
2.2
|
50.9
|
1.0
|
NE2
|
A:HIS360
|
2.3
|
37.9
|
1.0
|
CG
|
A:ASP359
|
2.7
|
50.1
|
1.0
|
CG
|
A:ASP172
|
2.8
|
57.4
|
1.0
|
CD2
|
A:HIS360
|
3.0
|
35.6
|
1.0
|
CB
|
A:THR210
|
3.0
|
45.7
|
1.0
|
CE1
|
A:HIS360
|
3.1
|
36.2
|
1.0
|
OD1
|
A:ASP359
|
3.1
|
54.5
|
1.0
|
OD2
|
A:ASP172
|
3.3
|
70.1
|
1.0
|
CA
|
A:THR210
|
3.3
|
44.4
|
1.0
|
CG2
|
A:THR210
|
3.3
|
43.5
|
1.0
|
CB
|
A:ASP359
|
3.9
|
47.2
|
1.0
|
N
|
A:THR210
|
3.9
|
43.9
|
1.0
|
CG
|
A:HIS360
|
3.9
|
35.4
|
1.0
|
CB
|
A:ASP172
|
3.9
|
51.6
|
1.0
|
ND1
|
A:HIS360
|
4.0
|
37.0
|
1.0
|
N
|
A:GLY173
|
4.0
|
43.2
|
1.0
|
CA
|
A:ASP172
|
4.0
|
47.5
|
1.0
|
O
|
A:HOH1003
|
4.2
|
31.5
|
1.0
|
C
|
A:ASP172
|
4.4
|
45.3
|
1.0
|
C
|
A:LYS209
|
4.6
|
45.1
|
1.0
|
C
|
A:THR210
|
4.6
|
42.3
|
1.0
|
CE1
|
A:HIS475
|
4.6
|
37.5
|
1.0
|
OD1
|
A:ASP312
|
4.7
|
46.9
|
1.0
|
CA
|
A:GLY173
|
4.8
|
45.5
|
1.0
|
CG
|
A:ASP312
|
4.8
|
48.3
|
1.0
|
NE2
|
A:HIS475
|
4.9
|
35.9
|
1.0
|
O
|
A:LYS209
|
4.9
|
42.9
|
1.0
|
CB
|
A:ASP312
|
4.9
|
47.6
|
1.0
|
O
|
A:THR210
|
5.0
|
40.3
|
1.0
|
N
|
A:HIS360
|
5.0
|
40.5
|
1.0
|
ZN
|
A:ZN903
|
5.0
|
46.1
|
1.0
|
|
Zinc binding site 3 out
of 4 in 4zg9
Go back to
Zinc Binding Sites List in 4zg9
Zinc binding site 3 out
of 4 in the Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn904
b:57.7
occ:1.00
|
NE2
|
B:HIS475
|
1.9
|
52.6
|
1.0
|
OD2
|
B:ASP312
|
1.9
|
42.8
|
1.0
|
O1
|
B:EDO911
|
2.1
|
46.5
|
1.0
|
NE2
|
B:HIS316
|
2.3
|
49.2
|
1.0
|
CE1
|
B:HIS475
|
2.4
|
52.7
|
1.0
|
CG
|
B:ASP312
|
2.6
|
48.2
|
1.0
|
OD1
|
B:ASP312
|
2.7
|
50.1
|
1.0
|
CE1
|
B:HIS316
|
3.1
|
50.8
|
1.0
|
CD2
|
B:HIS475
|
3.2
|
52.7
|
1.0
|
CD2
|
B:HIS316
|
3.4
|
49.1
|
1.0
|
C1
|
B:EDO911
|
3.5
|
55.6
|
1.0
|
ND1
|
B:HIS475
|
3.7
|
50.4
|
1.0
|
CG
|
B:HIS475
|
4.1
|
49.9
|
1.0
|
CB
|
B:ASP312
|
4.1
|
49.3
|
1.0
|
OG1
|
B:THR210
|
4.2
|
59.6
|
1.0
|
ND1
|
B:HIS316
|
4.3
|
50.5
|
1.0
|
C2
|
B:EDO911
|
4.4
|
61.0
|
1.0
|
CG
|
B:HIS316
|
4.5
|
52.0
|
1.0
|
OD2
|
B:ASP172
|
4.5
|
52.6
|
1.0
|
CE1
|
B:HIS360
|
4.5
|
49.6
|
1.0
|
CE
|
B:MET362
|
4.7
|
42.8
|
1.0
|
NE2
|
B:HIS360
|
4.8
|
50.8
|
1.0
|
ZN
|
B:ZN905
|
4.8
|
93.6
|
1.0
|
O2
|
B:EDO911
|
4.9
|
62.6
|
1.0
|
|
Zinc binding site 4 out
of 4 in 4zg9
Go back to
Zinc Binding Sites List in 4zg9
Zinc binding site 4 out
of 4 in the Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Structural Basis For Inhibition of Human Autotaxin By Four Novel Compounds within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn905
b:93.6
occ:1.00
|
OD1
|
B:ASP172
|
2.3
|
67.9
|
1.0
|
NE2
|
B:HIS360
|
2.4
|
50.8
|
1.0
|
OD2
|
B:ASP359
|
2.4
|
56.5
|
1.0
|
OG1
|
B:THR210
|
2.5
|
59.6
|
1.0
|
CG
|
B:ASP172
|
2.6
|
53.1
|
1.0
|
OD2
|
B:ASP172
|
2.7
|
52.6
|
1.0
|
CE1
|
B:HIS360
|
2.9
|
49.6
|
1.0
|
OD1
|
B:ASP359
|
3.0
|
54.2
|
1.0
|
CG
|
B:ASP359
|
3.0
|
51.8
|
1.0
|
CB
|
B:THR210
|
3.2
|
50.5
|
1.0
|
CG2
|
B:THR210
|
3.2
|
47.5
|
1.0
|
CD2
|
B:HIS360
|
3.4
|
50.8
|
1.0
|
CA
|
B:THR210
|
3.5
|
46.7
|
1.0
|
N
|
B:GLY173
|
3.8
|
46.8
|
1.0
|
CB
|
B:ASP172
|
3.8
|
52.0
|
1.0
|
ND1
|
B:HIS360
|
3.9
|
48.1
|
1.0
|
CA
|
B:ASP172
|
4.0
|
48.5
|
1.0
|
N
|
B:THR210
|
4.2
|
44.3
|
1.0
|
CG
|
B:HIS360
|
4.2
|
46.0
|
1.0
|
OD2
|
B:ASP312
|
4.2
|
42.8
|
1.0
|
C
|
B:ASP172
|
4.3
|
46.3
|
1.0
|
CE1
|
B:HIS475
|
4.4
|
52.7
|
1.0
|
CG
|
B:ASP312
|
4.4
|
48.2
|
1.0
|
CB
|
B:ASP359
|
4.5
|
49.5
|
1.0
|
CB
|
B:ASP312
|
4.5
|
49.3
|
1.0
|
NE2
|
B:HIS475
|
4.5
|
52.6
|
1.0
|
CA
|
B:GLY173
|
4.6
|
48.7
|
1.0
|
OH
|
B:TYR307
|
4.6
|
47.4
|
1.0
|
ZN
|
B:ZN904
|
4.8
|
57.7
|
1.0
|
C
|
B:THR210
|
4.8
|
45.2
|
1.0
|
C
|
B:LYS209
|
4.9
|
42.2
|
1.0
|
ND1
|
B:HIS475
|
5.0
|
50.4
|
1.0
|
|
Reference:
A.J.Stein,
G.Bain,
P.Prodanovich,
A.M.Santini,
J.Darlington,
N.M.Stelzer,
R.S.Sidhu,
J.Schaub,
L.Goulet,
D.Lonergan,
I.Calderon,
J.F.Evans,
J.H.Hutchinson.
Structural Basis For Inhibition of Human Autotaxin By Four Potent Compounds with Distinct Modes of Binding. Mol.Pharmacol. V. 88 982 2015.
ISSN: ESSN 1521-0111
PubMed: 26371182
DOI: 10.1124/MOL.115.100404
Page generated: Sun Oct 27 11:45:25 2024
|